Risi, E., Biagioni, C., Benelli, M., Migliaccio, I., McCartney, A., Bonechi, M., . . . Malorni, L. (2019). An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: A substudy of the NeoALTTO trial (BIG 1-06). Ther Adv Med Oncol.
Citação norma ChicagoRisi, Emanuela, et al. "An RB-1 Loss of Function Gene Signature As a Tool to Predict Response to Neoadjuvant Chemotherapy Plus Anti-HER2 Agents: A Substudy of the NeoALTTO Trial (BIG 1-06)." Ther Adv Med Oncol 2019.
Citação norma MLARisi, Emanuela, et al. "An RB-1 Loss of Function Gene Signature As a Tool to Predict Response to Neoadjuvant Chemotherapy Plus Anti-HER2 Agents: A Substudy of the NeoALTTO Trial (BIG 1-06)." Ther Adv Med Oncol 2019.